# Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning

> Research article (European Journal of Cancer, 2018) · cited 59× · AI/ML

**Wikidata**: [openalex:W2904795088](https://www.wikidata.org/wiki/openalex:W2904795088)  
**Source**: https://4ort.xyz/entity/contrast-enhancement-is-a-prognostic-factor-in-idh1-2-mutant-but-not-in-wild-type-who-grade-ii-iii-glioma-as-confirmed-b